Guidance for publishing BADBIR findings

Information on authorship, acknowledgement and including statements when publishing BADBIR findings.

Authorship

When publishing findings we suggest that authorship is discussed before starting to draft the publication so that there is consensus and the work of all contributors is suitably recognised.

The ICMJE criteria for authorship and the CREDIT taxonomy offer helpful information about the different contributions that are made when preparing publications.

We advise that the named authors on BADBIR papers are those who have:

• Made a relevant and substantial contribution to the conception and design, collection of data, or analysis and interpretation of the data
• Drafted the article or revised it critically for important intellectual content
• Provided final approval of the version to be published, in line with the Uniform Requirements for Manuscripts Submitted for Biomedical Journals

For publications based on BADBIR’s active research questions list, the statement “on behalf of the BADBIR Study Group” is also to be included at the end of the named author list. Active research questions are the research questions that the Committee has approved and assigned to a group.

Full details can be found in our Authorship Policy.

How to acknowledge the BADBIR data

When findings from the BADBIR data are published, we request that the approved acknowledgement statements below are used so that the work of all contributors is suitably recognised.

The statement will depend on the category of the research. These are summarised below and full details can be found in our Authorship Policy.

1. For publications based on BADBIR’s active research questions listThe paper is published with the dataset provided by BADBIR. BADBIR is one of the largest psoriasis registries in the world with over 20,000 registrations. We are grateful to all participating centres who contribute data and to participants who consent to being part of BADBIR.

   The BADBIR Study Group comprises the BADBIR Steering Committee and the BADBIR Data Monitoring Committee (DCM). BADBIR Steering Committee members.

   Members of the DMC are: Prof Anja Strangfeld (Chair), Dr Girish Gupta, Imke Redeker and Dr Richard Weller

2. For publications arising from independent investigators or BAD members

   This publised paper is published with the dataset provided by BADBIR is one of the largest psoriasis registries in the world with over 20,000 registrations. We are grateful to all participating centres who contribute data and to participants who consent to being part of BADBIR.

   The BADBIR Study Group comprises the BADBIR Steering Committee and the BADBIR Data Monitoring Committee (DCM). BADBIR Steering Committee members.

   Members of the DMC are: Prof Anja Strangfeld (Chair), Dr Girish Gupta, Imke Redeker and Dr Richard Weller.

3. For publications by pharmaceutical companies who are involved with BADBIR and are publishing an independent study.This paper is published with the dataset provided by BADBIR. BADBIR is one of the largest psoriasis registries in the world with over 20,000 registrations. We are grateful to all participating centres who contribute data and to participants who consent to being part of BADBIR.

Funding statement

View the funding statement that should be used for all BADBIR publications:

• Authorship Policy

Data availability statement

Some restrictions apply to the BADBIR, data meaning it may not be possible to make the data used in your publication available to others. Find out more:

• Authorship Policy

How to apply to use BADBIR data

If you are interested in applying to use BADBIR data to carry out some analysis, the details of how to apply can be found on the Using BADBIR data page